Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 52 min ago
PreprintAll rights reservedbioRxiv

A novel KIR3DL2-directed CAR T-cell therapy for cutaneous and systemic T-cell lymphomas

  • F. M. Aletti
  • J. Weng
  • C. C. Le
  • J. Liu
  • F. Darbaniyan
  • A. Rehman
  • M. D. Richard
  • S. Kolsuz
  • X. Cheng
  • S. Patchva
  • Y. Tang
  • C.-Y. Lin
15 more authors
  • J. Cao
  • K. Singh
  • S. D. Reddy
  • S. G. Rawat
  • S. Mohapatra
  • J. Wei
  • K. Chohan
  • C. Kettlun Leyton
  • N. J. Dcunha
  • N. Saini
  • F. Chu
  • M. R. Green
  • S. P. Iyer
  • F. Vega
  • S. S. Neelapu1
  1. 1The University of Texas MD Anderson Cancer Center
Read full textPDFDOICite

Related

  1. Gut microbiome in cutaneous T-cell lymphoma: emerging insights into systemic immunity and the gut-skin-tumor axis
    Sarayu Balachandar, Sophia W. Xia, Madeline J. Hooper +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyCrossref
  2. Clonal expansion of CAR-T cells harboring lentivector integration in the PLAAT4 gene following anti-CD19 CAR T-cell therapy in a context of cutaneous T-cell lymphoma
    Vincent Guiraud, Clotilde Bravetti, Amélie Guihot +13
    HaematologicaPeer-reviewedCC BY-NC 4.0Full textImmunologyOncologyHAL
  3. Cutaneous efficacy and glucocorticoid-sparing effects of anifrolumab in systemic lupus erythematosus: a systematic review and meta-analysis of randomized controlled trials
    Jianing Wang, Feiyin Liu, Qianwen Lou +2
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMCCrossref
  4. Antigen availability as a determinant of GPC3-directed CAR-T therapy in hepatocellular carcinoma
    Xulin Guo, Ping Sun, Wen Yu +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  5. AXL-directed antibody–drug conjugate therapy in soft-tissue sarcoma
    Nathan El-Ghazzi, Tony Sourisseau, Vanessa Chaire +7
    Journal of Hematology and OncologyPeer-reviewedCC BY 4.0Full textGeneral biologyOncologyHAL

Cite

BibTeXRIS
BibTeX
@misc{aletti2026novel,
  title = {{A novel KIR3DL2-directed CAR T-cell therapy for cutaneous and systemic T-cell lymphomas}},
  author = {F. M. Aletti and J. Weng and C. C. Le and J. Liu and F. Darbaniyan and A. Rehman and M. D. Richard and S. Kolsuz and X. Cheng and S. Patchva and Y. Tang and C.-Y. Lin and J. Cao and K. Singh and S. D. Reddy and S. G. Rawat and S. Mohapatra and J. Wei and K. Chohan and C. Kettlun Leyton and N. J. Dcunha and N. Saini and F. Chu and M. R. Green and S. P. Iyer and F. Vega and S. S. Neelapu},
  howpublished = {bioRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.05.764385},
  url = {https://www.biorxiv.org/content/10.64898/2026.11.05.764385v1},
}
RIS
TY  - UNPB
TI  - A novel KIR3DL2-directed CAR T-cell therapy for cutaneous and systemic T-cell lymphomas
AU  - F. M. Aletti
AU  - J. Weng
AU  - C. C. Le
AU  - J. Liu
AU  - F. Darbaniyan
AU  - A. Rehman
AU  - M. D. Richard
AU  - S. Kolsuz
AU  - X. Cheng
AU  - S. Patchva
AU  - Y. Tang
AU  - C.-Y. Lin
AU  - J. Cao
AU  - K. Singh
AU  - S. D. Reddy
AU  - S. G. Rawat
AU  - S. Mohapatra
AU  - J. Wei
AU  - K. Chohan
AU  - C. Kettlun Leyton
AU  - N. J. Dcunha
AU  - N. Saini
AU  - F. Chu
AU  - M. R. Green
AU  - S. P. Iyer
AU  - F. Vega
AU  - S. S. Neelapu
PY  - 2026
DA  - 2026/11/05
PB  - bioRxiv
DO  - 10.64898/2026.11.05.764385
UR  - https://www.biorxiv.org/content/10.64898/2026.11.05.764385v1
ER  -